Business
Board Appointment
Board Appointment.
About this update from Poolbeg Pharma Plc
[{"type":"text","content":"\n\nPoolbeg Pharma plc\n \nBoard Appointment\n \n24 May 2023 - Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, announces the appointment of Brendan Buckley as an Independent Non-Executive Director of the Company with immediate effect. Brendan will also replace Cathal Friel as a member of the Remuneration Committee.\n \nProfessor Buckley is the former Chief Medical Officer of ICON plc, a medical graduate of University College Cork and a doctoral graduate in Biochemistry in the Faculty of Medicine at Oxford University. Prof Buckley has advised Poolbeg since inception and has deep experience in metabolic diseases including over 40 years' experience in clinical practice as a Consultant Physician in endocrinology, diabetes and in academic clinical pharmacology. Brendan was a member of the Board of Directors of the Irish Medicines Board (now the Health Products Regulatory Authority), chairing its statutory Advisory Committee for Human Medicines. He was also a member of the European Medicines Agency Committee for Orphan Medicinal Products (COMP) and of the European Medicines Agency Scientific Advisory Committee on diabetes and metabolism. Brendan has published over 150 scientific papers, mainly on metabolic disease, as well as the recent key opinion-leading book 'Re-Engineering Clinical Trials'.\n \nJeremy Skillington, PhD, CEO of Poolbeg Pharma, said: \"We are delighted to have Brendan join the Board of Directors. His significant contribution to Poolbeg during his role as a member of the Scientific Advisory Board, and his considerable industry experience will be of tremendous benefit as we continue to pursue our goal of becoming a one-stop-shop for pharma and biotechs seeking products to in-license.\"\n \nBrendan Buckley, Non-Executive Director of Poolbeg Pharma, said:\" I am honoured to be joining the Board at this exciting time of the Company's development. Poolbeg has a unique model and pipeline and I look forward to working alongside such a strong Management Team targeting a number of growing markets.\"\n \nRegulatory Disclosures\n \nThe following disclosures are required under Schedule Two, paragraph (g) of ...